The Evolution of Pharmaceutical Three-Dimensional Printing

Dear Colleagues,

Over the past quarter-century, pharmaceutical three-dimensional printing has developed rapidly and changed the way we think about the manufacturing process, especially in terms of tailored medicine. The use of additive manufacturing technologies opens a new opportunity for researchers to overcome major issues in the development of drug delivery systems, such as improving poorly water-soluble drug dissolution, controlling the release of API, and many others. Some 3D printing technologies have already been utilized to manufacture drug delivery systems, i.e., fused-deposition modelling, selective laser sintering, stereolithography, drop-on-powder, and more. After the introduction of Spritam^® to the pharmaceutical market, the amount of research in this area has rapidly increased and brought new solutions for pharmaceutical technology. However, many fields are still waiting to be explored for patient benefit.

This Special Issue is focused on highlighting the current trends and future perspectives in the pharmaceutical 3D-printing field.

Dr. Mateusz Kurek
Dr. Witold Jamróz
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.